112 related articles for article (PubMed ID: 15330122)
21. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.
Shiver JW; Emini EA
Annu Rev Med; 2004; 55():355-72. PubMed ID: 14746526
[TBL] [Abstract][Full Text] [Related]
22. AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination.
van Ballegooijen M; Bogaards JA; Weverling GJ; Boerlijst MC; Goudsmit J
J Acquir Immune Defic Syndr; 2003 Oct; 34(2):214-20. PubMed ID: 14526211
[TBL] [Abstract][Full Text] [Related]
23. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.
Vogels R; Zuijdgeest D; van Rijnsoever R; Hartkoorn E; Damen I; de Béthune MP; Kostense S; Penders G; Helmus N; Koudstaal W; Cecchini M; Wetterwald A; Sprangers M; Lemckert A; Ophorst O; Koel B; van Meerendonk M; Quax P; Panitti L; Grimbergen J; Bout A; Goudsmit J; Havenga M
J Virol; 2003 Aug; 77(15):8263-71. PubMed ID: 12857895
[TBL] [Abstract][Full Text] [Related]
24. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.
Casimiro DR; Chen L; Fu TM; Evans RK; Caulfield MJ; Davies ME; Tang A; Chen M; Huang L; Harris V; Freed DC; Wilson KA; Dubey S; Zhu DM; Nawrocki D; Mach H; Troutman R; Isopi L; Williams D; Hurni W; Xu Z; Smith JG; Wang S; Liu X; Guan L; Long R; Trigona W; Heidecker GJ; Perry HC; Persaud N; Toner TJ; Su Q; Liang X; Youil R; Chastain M; Bett AJ; Volkin DB; Emini EA; Shiver JW
J Virol; 2003 Jun; 77(11):6305-13. PubMed ID: 12743287
[TBL] [Abstract][Full Text] [Related]
25. Antibody neutralization and escape by HIV-1.
Wei X; Decker JM; Wang S; Hui H; Kappes JC; Wu X; Salazar-Gonzalez JF; Salazar MG; Kilby JM; Saag MS; Komarova NL; Nowak MA; Hahn BH; Kwong PD; Shaw GM
Nature; 2003 Mar; 422(6929):307-12. PubMed ID: 12646921
[TBL] [Abstract][Full Text] [Related]
26. Public health. AIDS vaccine trial produces disappointment and confusion.
Cohen J
Science; 2003 Feb; 299(5611):1290-1. PubMed ID: 12610260
[No Abstract] [Full Text] [Related]
27. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
[TBL] [Abstract][Full Text] [Related]
28. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
29. Replication-defective vector based on a chimpanzee adenovirus.
Farina SF; Gao GP; Xiang ZQ; Rux JJ; Burnett RM; Alvira MR; Marsh J; Ertl HC; Wilson JM
J Virol; 2001 Dec; 75(23):11603-13. PubMed ID: 11689642
[TBL] [Abstract][Full Text] [Related]
30. Evolution and transmission of stable CTL escape mutations in HIV infection.
Goulder PJ; Brander C; Tang Y; Tremblay C; Colbert RA; Addo MM; Rosenberg ES; Nguyen T; Allen R; Trocha A; Altfeld M; He S; Bunce M; Funkhouser R; Pelton SI; Burchett SK; McIntosh K; Korber BT; Walker BD
Nature; 2001 Jul; 412(6844):334-8. PubMed ID: 11460164
[TBL] [Abstract][Full Text] [Related]
31. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Amara RR; Villinger F; Altman JD; Lydy SL; O'Neil SP; Staprans SI; Montefiori DC; Xu Y; Herndon JG; Wyatt LS; Candido MA; Kozyr NL; Earl PL; Smith JM; Ma HL; Grimm BD; Hulsey ML; Miller J; McClure HM; McNicholl JM; Moss B; Robinson HL
Science; 2001 Apr; 292(5514):69-74. PubMed ID: 11393868
[TBL] [Abstract][Full Text] [Related]
32. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
J Virol; 2001 Jun; 75(11):5151-8. PubMed ID: 11333896
[TBL] [Abstract][Full Text] [Related]
33. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
Belshe RB; Stevens C; Gorse GJ; Buchbinder S; Weinhold K; Sheppard H; Stablein D; Self S; McNamara J; Frey S; Flores J; Excler JL; Klein M; Habib RE; Duliege AM; Harro C; Corey L; Keefer M; Mulligan M; Wright P; Celum C; Judson F; Mayer K; McKirnan D; Marmor M; Woody G;
J Infect Dis; 2001 May; 183(9):1343-52. PubMed ID: 11294665
[TBL] [Abstract][Full Text] [Related]
35. Development of a preventive vaccine for Ebola virus infection in primates.
Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
[TBL] [Abstract][Full Text] [Related]
36. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
[TBL] [Abstract][Full Text] [Related]
37. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren PW; Moore JP; Burton DR; Sattentau QJ
AIDS; 1999; 13 Suppl A():S137-62. PubMed ID: 10885772
[No Abstract] [Full Text] [Related]
38. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
Seth A; Ourmanov I; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Wyatt L; Carroll M; Moss B; Venzon D; Letvin NL; Hirsch VM
J Virol; 2000 Mar; 74(6):2502-9. PubMed ID: 10684264
[TBL] [Abstract][Full Text] [Related]
39. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
Davis NL; Caley IJ; Brown KW; Betts MR; Irlbeck DM; McGrath KM; Connell MJ; Montefiori DC; Frelinger JA; Swanstrom R; Johnson PR; Johnston RE
J Virol; 2000 Jan; 74(1):371-8. PubMed ID: 10590126
[TBL] [Abstract][Full Text] [Related]
40. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
Evans TG; Keefer MC; Weinhold KJ; Wolff M; Montefiori D; Gorse GJ; Graham BS; McElrath MJ; Clements-Mann ML; Mulligan MJ; Fast P; Walker MC; Excler JL; Duliege AM; Tartaglia J
J Infect Dis; 1999 Aug; 180(2):290-8. PubMed ID: 10395842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
